Organizing pneumonia associated with rituximab: Challenges raised by establishing causality

Joint Bone Spine

Volumn 75, Issue 3, 2008, Pages 260-262

  Lioté, Huguette ^a  

^a HÔPITAL TENON   (France)

Author keywords

Drug induced; Organizing pneumonia; PneumoDoc; Pneumonitis; Rheumatoid arthritis; Rituximab

Indexed keywords

METHYLPREDNISOLONE; RITUXIMAB;

ADULT RESPIRATORY DISTRESS SYNDROME; B CELL LYMPHOMA; BRONCHOSPASM; CHRONIC LYMPHATIC LEUKEMIA; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DRUG INFORMATION; EARLY DIAGNOSIS; EDITORIAL; HUMAN; INJECTION SITE REACTION; LUNG INFILTRATE; MANDATORY TESTING; NONHODGKIN LYMPHOMA; PATIENT EDUCATION; PNEUMONIA; RISK FACTOR;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CAUSALITY; HUMANS; IMMUNOLOGIC FACTORS; PNEUMONIA;

EID: 42749086209     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2008.02.001     Document Type: Editorial

References (23)

1. Mayaud C., Fartoukh M., Parrot A., et al. Les pneumopathies infiltrantes d'origine médicamenteuses: un problème avant tout diagnostique. Rev Pneumol Clin 61 (2005) 179-185
2. Lioté H., Séroussi B., Bouaud J., et al. Formalisation de la démarche diagnostique des pneumopathies médicamenteuses: le système PneumoDoc. Rev Pneumol Clin 63 (2007) 193-201
3. Soubrier M., Jeanin G., Kemeny J.L., et al. Organizing pneumonia after rituximab therapy: two cases. Joint Bone Spine 75 (2007) 362-365
4. Kimby E. Tolerability and safety of rituximab (MabThera). Cancer Treat Rev 31 (2005) 456-473
5. Smolen J.S., Keystone E.C., Emery P., et al., Working Group on the Rituximab Consensus Statement. Consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann Rheum Dis 66 (2007) 143-150
6. Montero A.J., McCarthy J.J., Chen G., et al. Acute respiratory distress syndrome after rituximab infusion. Int J Hematol 82 (2005) 324-326
7. Byrd J.C., Peterson B.L., Morrison V.A., et al. Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712). Blood 101 (2003) 6-14
8. Kanelli S., Ansell S.M., Habermann T.M., et al. Rituximab toxicity in patients with peripheral blood malignant B-cell lymphocytosis. Leuk Lymphoma 42 (2001) 1329-1337
9. Burton C., Kaczmarski R., and Jan-Mohamed R. Interstitial pneumonitis related to rituximab therapy. New Engl J Med 348 (2003) 2690-2691
10. Jullien V., Perrin C., Peyrade F., et al. Une pneumopathie alvéolo-interstitielle hypoxémiante associée à la prise de rituximab. Rev Mal Respir 21 (2004) 407-410
11. Saito B., Nakamaki T., Adachi D., et al. Acute respiratory distress syndrome during the third infusion of rituximab in a patient with follicular lymphoma. Int J Hematol 80 (2004) 164-167
12. Feenstra J.F., Hickey B.P., and Blackwell E.A. Acute respiratory failure associated with cladribine pneumonitis. Intern Med J 34 (2004) 583-584
13. Leon R.J., Gonsalvo A., Salas R., et al. Rituximab-induced acute pulmonary fibrosis. Mayo Clin Proc 79 (2004) 949 953
14. Alexandrescu D.T., Dutcher J.P., O'Boyle K., et al. Fatal intra-alveolar hemorrhage after rituximab in a patient with non-Hodgkin lymphoma. Leuk Lymphoma 45 (2004) 2321-2325
15. Swords R., Power D., Fay M., et al. Interstitial pneumonitis following rituximab therapy for immune thrombocytopenic purpura (ITP). Am J Hematol 77 (2004) 103-104
16. Macartney C., Burke E., Elborn S., et al. Bronchiolitis obliterans organizing pneumonia in a patient with non-Hodgkin's lymphoma following R-CHOP and pegylated filgrastim. Leuk Lymphoma 46 (2005) 1523-1526
17. Herishanu Y., Polliack A., Leider-Trejo L., et al. Fatal interstitial pneumonitis related to rituximab-containing regimen. Clin Lymphoma Myeloma 6 (2006) 407-409
18. Mian M., Rass C., Hutarew G., et al. Extensive organizing pneumonia during chemo-immunotherapy containing rituximab and G-CSF in a patient with diffuse large B-cell lymphoma: case report and review of the literature. Leuk Lymphoma 47 (2006) 1683-1685
19. Biehn S.E., Kirk D., Rivera M.P., et al. Bronchiolitis obliterans with organizing pneumonia after rituximab therapy for non-Hodgkin's lymphoma. Hematol Oncol 24 (2006) 234-237
20. Lee Y., Kyung S.Y., Choi S.J., et al. Two cases of interstitial pneumonitis caused by rituximab therapy. Korean J Intern Med 21 (2006) 183-186
21. Hiraga J., Kondoh Y., Taniguchi H., et al. A case of interstitial pneumonia induced by rituximab therapy. Int J Hematol 81 (2005) 169-170
22. Mokhtari M., Bach P.B., Tietjen P.A., et al. Bronchiolitis obliterans organizing pneumonia in cancer: a case series. Respir Med 96 (2002) 280-286
23. www.pneumotox.com